Scapa Healthcare

Scapa Healthcare opened a new 52,000 square foot medical device manufacturing facility in Knoxville, Tennessee, representing a $31 million investment and expected to create 100 new jobs over five years.

Scapa Healthcare inaugurated a new 152,000-square-foot medical device manufacturing facility in Knox County, Tennessee on June 3, 2019. The facility is expected to create 100 new jobs over five years.

Scapa Healthcare has signed an agreement to purchase the Systagenix manufacturing facility in Gargrave, England from Acelity. The 335,000-square-foot site will be transferred to Scapa Healthcare along with a long-term manufacturing and supply agreement for advanced wound dressings.

Scapa Healthcare opened a new 152,000-square-foot medical device manufacturing facility in Knoxville, Tennessee, to support its growth strategy and house equipment from technology transfers.

Scapa Healthcare acquired Biomed Laboratories, expanding its portfolio to include topical skin care products such as liquids, creams, gels, lotions, powders and hot fill waxes for advanced wound care, ostomy and consumer wellness markets.

Scapa Healthcare broke ground on a new 152,000-square-foot medical device manufacturing facility in Hardin Business Park, Knox County, Tennessee. The $31 million investment is expected to create more than 100 new jobs over five years.

Scapa Healthcare will expand its Knoxville, Tennessee operations by constructing a 150,000-square-foot facility, investing approximately $40 million and creating more than 85 new jobs. The company will consolidate three existing buildings into the new single location.